Part of the Physical Sciences and Mathematics Commons

Works by Yibin Wang in Physical Sciences and Mathematics

2021

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

2020

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Lili Yu

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Lili Yu

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Lili Yu

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Karl E. Peace

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

2013

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Karl E. Peace

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Biostatistics Faculty Publications

2010

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Biostatistics Faculty Publications

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace